Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by wexworthon Jul 31, 2020 9:12am

152 Views

Post# 31348660

RE:Bid continues to drop

Buy more or shut the trap? Lol.

Pre R&F we we trading at 6-10 cents. I guess people who bought much higher are sour, and I get that.

I think we will see some very acceptable revenue come in from that agreement, we will need to just be patient.

As for the stock price, do what most smart investors do/ buy when others are selling and sell when others are buying.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal